Stay updated on Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.

Latest updates to the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe footer now displays Revision: v3.6.3, replacing v3.6.2, indicating a new site release was deployed.SummaryDifference0.0%

- Check18 days agoChange DetectedFooter now shows Revision: v3.6.2, replacing the previous v3.6.0. This reflects a newer platform release behind the scenes.SummaryDifference0.0%

- Check32 days agoChange DetectedThe record now shows 'No longer looking for participants', indicating recruitment has ended, and the revision has been updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check39 days agoChange DetectedA new 'Study Status' entry was added to the history, indicating an update to how status information is presented. The release history shows an upgrade to version v3.5.5 (2026-06-04), replacing v3.5.4, reflecting a platform update to the record-keeping UI.SummaryDifference0.2%

- Check61 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, representing a new version of the page’s release notes. This change updates the displayed documentation/versioning on the page.SummaryDifference0.0%

- Check82 days agoChange DetectedThis update reflects routine ClinicalTrials.gov record-history versioning, including a revision from v3.5.2 to v3.5.3 and indicating that the study record was revised around 2026-04-20/2026-04-23 for the “Study Design” and “Study Status” sections. It represents an additional submitted version of the same study record rather than a clearly substantive, user-critical change based on the provided diff.SummaryDifference0.2%

Stay in the know with updates to Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.